Pharming Group N.V. ADR PHAR 深 沪
已收盘 08-01 16:00:00 美东时间
10.96
-0.150
-1.35%
华盛通- 最 高11.29
- 今 开10.71
- 成交量 2.30万股
- 最 低 10.5482
- 昨 收 11.11
- 总市值 7.50亿
- 52周最高 12.61
- 市盈率 静 --
- 换手率 0.03%
- 52周最低 6.73
- 委 比 -76.10%
- 总股本 6839.31万
- 历史最高 21.99
- 量 比 2.42
- 振 幅 6.68%
- 历史最低 6.10
- 每 手 1
- 风险率 1.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jubilant Pharmova Opens Special Window for Share Transfer Requests
The latest announcement is out from Jubilant Pharmova Limited ( ($IN:JUBLPHARMA...
08-02 02:24
Jubilant Pharmova to Transfer Unclaimed Dividends to IEPF
Jubilant Pharmova Limited ( ($IN:JUBLPHARMA) ) has shared an update. Jubilant P...
08-02 02:23
Pharos Energy Updates Total Voting Rights
Pharos Energy ( ($GB:PHAR) ) has provided an update. Pharos Energy plc announce...
07-31 17:43
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Pharming Raises FY2025 Sales Guidance from $325.000M-$340.000M to $335.000M-$350.000M vs $327.467M Est
Pharming (NASDAQ:PHAR) raises FY2025 sales outlook from $325.000 million-$340.000 million to $335.000 million-$350.000 million vs $327.467 million estimate.
07-31 13:16
Pharming Q2 EPS $0.06 Beats $(0.03) Estimate, Sales $93.20M Beat $82.63M Estimate
Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.03) by 340 percent. This is a 400 percent increase over losses of $(0.02) per share from the same
07-31 13:13
Theravance Biopharma to Report Second Quarter 2025 Financial Results on August 12, 2025
DUBLIN, July 28, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2025 financial results and provide a business update after market close on Tues...
07-28 18:00
Pharos Energy Cancels Treasury Shares to Enhance Transparency
Pharos Energy ( ($GB:PHAR) ) has provided an announcement. Pharos Energy plc an...
07-23 22:22
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
Pharming Group N.V. announce plans to report preliminary financial results for Q2 and H1 2025 on July 31, 2025, alongside a business update. A conference call and webcast for analysts and investors will be held at 13:30 CEST/07:30 EDT, requiring advance registration via provided links. For more information, visit www.pharming.com.
07-17 06:00
渤小海伴您读研报之天坛生物
（转自：渤海证券财富管理） 1.公司简介 公司主营业务为血液制品研发、生产和销售，主要产品包括人血白蛋白、人免疫球蛋白、人凝血因子三大类15个品种...
07-08 10:07
